{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:59:56Z","timestamp":1787979596015,"version":"build-2784847793"},"reference-count":15,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>With our increasing understanding of inherited marrow failure and myeloid malignancy predisposition syndromes, it has become clear that there is a wide phenotypic spectrum and that these diseases must be considered in the differential diagnosis of both children and adults with unexplained defects in hematopoiesis. Moreover, these conditions are not as rare as previously believed and may present as aplastic anemia, myelodysplastic syndrome, or malignancy over a range of ages. Establishing the correct diagnosis is essential because it has implications for treatment, medical management, cancer screening, and family planning. Our goal is to highlight insights into the pathophysiology of these diseases, review cryptic presentations of these syndromes, and provide useful references for the practicing hematologist.<\/jats:p>","DOI":"10.1182\/hematology.2021000246","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:08:35Z","timestamp":1639138115000},"page":"153-156","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["When to worry about inherited bone marrow failure and myeloid malignancy predisposition syndromes in the setting of a hypocellular marrow"],"prefix":"10.1182","volume":"2021","author":[{"given":"Anupama","family":"Narla","sequence":"first","affiliation":[{"name":"Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"2021121012063974800_hem2021000246C1","first-page":"307","article-title":"Hypoplastic anemia","volume":"15","author":"Diamond","year":"1938","journal-title":"Am J Dis Child"},{"issue":"16","key":"2021121012063974800_hem2021000246C2","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1182\/blood-2009-10-178129","article-title":"Ribosomopathies: human disorders of ribosome dysfunction","volume":"115","author":"Narla","year":"2010","journal-title":"Blood"},{"issue":"7176","key":"2021121012063974800_hem2021000246C3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature06494","article-title":"Identification of RPS14 as a 5q- syndrome gene by RNA interference screen","volume":"451","author":"Ebert","year":"2008","journal-title":"Nature"},{"issue":"1","key":"2021121012063974800_hem2021000246C4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: new players and therapeutic avenues","volume":"18","author":"Pelletier","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2021121012063974800_hem2021000246C5","first-page":"219","article-title":"Atrophia cutis reticularis cum pigmentations, dystrophia unguium at leukoplakis oris (poikioodermia atrophicans vascularis Jacobi)","volume":"5","author":"Zinsser","year":"1910","journal-title":"Ikonographia Dermatologica"},{"issue":"2","key":"2021121012063974800_hem2021000246C6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","article-title":"Dyskeratosis congenita","volume":"23","author":"Savage","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10","key":"2021121012063974800_hem2021000246C7","doi-asserted-by":"crossref","first-page":"E2358","DOI":"10.1073\/pnas.1720427115","article-title":"Diagnostic utility of telomere length testing in a hospital-based setting","volume":"115","author":"Alder","year":"2018","journal-title":"PNAS"},{"issue":"22","key":"2021121012063974800_hem2021000246C8","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood.2019003264","article-title":"Cancer spectrum and outcomes in the Mendelian short telomere syndromes","volume":"135","author":"Schratz","year":"2020","journal-title":"Blood"},{"issue":"11","key":"2021121012063974800_hem2021000246C9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nrc2009","article-title":"Guido Fanconi (1892-1979): a jack of all trades","volume":"6","author":"Lobitz","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2021121012063974800_hem2021000246C10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.seminhematol.2006.04.005","article-title":"Fanconi anemia","volume":"43","author":"Bagby","year":"2006","journal-title":"Semin Hematol"},{"issue":"5","key":"2021121012063974800_hem2021000246C11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-3476(64)80150-5","article-title":"The syndrome of pancreatic insufficiency and bone marrow dysfunction","volume":"65","author":"Shwachman","year":"1964","journal-title":"J Pediatr"},{"issue":"1","key":"2021121012063974800_hem2021000246C12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.hoc.2012.10.003","article-title":"Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update","volume":"27","author":"Myers","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"2021121012063974800_hem2021000246C13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng1062","article-title":"Mutations in SBDS are associated with Shwachman-Diamond syndrome","volume":"33","author":"Boocock","year":"2003","journal-title":"Nat Genet"},{"issue":"10","key":"2021121012063974800_hem2021000246C14","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"issue":"26","key":"2021121012063974800_hem2021000246C15","first-page":"3591","article-title":"VEXAS syndrome","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/153\/1851462\/153narla.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/153\/1851462\/153narla.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T12:08:51Z","timestamp":1639138131000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2021\/1\/153\/482953\/When-to-worry-about-inherited-bone-marrow-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,10]]},"published-print":{"date-parts":[[2021,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2021000246","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,10]]},"published":{"date-parts":[[2021,12,10]]}}}